CClinicalTrials.gg
CompletedNCT06835764NOVELAUpdated Jun 30, 2026Results posted

A Telenovela Intervention for Caregivers of African-American and Hispanic Hospice Patients

An interventional study of NOVELA in Hospice and Caregivers, sponsored by Johns Hopkins University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-30.

Sponsored by Johns Hopkins University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This randomized clinical trial (RCT) intends to look at the preliminary efficacy of NOVELA (intervention group) in changing anxiety and self-efficacy compared to usual hospice care (control group). In the NOVELA intervention, hospice care will be enhanced with the telenovela videos for hospice family caregivers (HFCG) education during twice weekly hospice telehealth visits to prepare caregivers for proper use of hospice support and healthcare services.

Read the detailed description

Telenovela is a television drama or soap opera that can be used to lead viewers to contemplate and discuss critical issues through video storytelling. Prior work showed informational telenovelas had a positive effect on Latino family caregivers' attitudes toward end-of-life (EOL) care services. The role of videos in hospice and palliative care shows significant promise, underscoring the videos as a mode of education for family caregivers that could potentially enhance caregiver's self-efficacy, decrease caregiver's anxiety, and reduce burnout. Despite the value of video education, many programs have failed to provide engaging material.

Based on input from HFCG, the investigators have produced a bilingual (Spanish and English version) four chapter telenovela video series (To Care/ El privilegio de cuidar) as part of NCI funded diversity supplement study. Founded upon extensive preliminary work, To Care portrays the journey of one hospice family as the family struggle with the hospice decision, pain management, decision-making, and finally the dying process. Averaging only 4:65 minutes, each chapter addresses one of these problems, validating family experiences and identifying potential solutions.

In a follow-up study, the investigators developed an interventionist-led conversation guide as a companion for the telenovela. The intervention, which includes the video series and the conversation guide, is named NOVELA (short for telenovela). The investigators preliminary single-arm trial found NOVELA feasible and acceptable in the hospice setting, with promising improvements in caregiver anxiety symptoms. Thus, storytelling and culturally tailored videos can be powerful tools to educate family caregivers of hospice patients. The overall expectation is that NOVELA will improve self-efficacy thus lowering anxiety in hospice family caregivers.

This proposal has the following aims:

  • Specific Aim 1: Investigate the preliminary efficacy of delivering NOVELA to African American (AA) and Hispanic HFCGs of cancer patients.
  • Specific Aim 2: Evaluate the benefits of NOVELA as perceived by hospice staff.
02

Conditions studied

  • Hospice
  • Caregivers

Browse trials for

Keywords

  • videos
  • hospice family caregivers
  • education
  • telenovelas
  • self-efficacy
  • anxiety
  • feasibility
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 62 is below the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Johns Hopkins University is the lead sponsor of 1,783 studies on the registry; 313 are open to participants now.

Of its 203 completed or terminated interventional studies of FDA-regulated products, 140 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Identified family caregiver of patients enrolled in hospice
  • Caregivers must be over the age of 18
  • Without cognitive impairment
  • With access to wireless device and internet.

Exclusion criteria

Exclusion Criteria:

  • HFCG of patients that are actively dying
  • Caregivers younger than 18 years
  • With cognitive impairment
  • Without internet access.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
62 participants (actual)

Study arms

  • Experimental
    NOVELA

    Hospice family caregivers will work with the interventionist to use a web-enabled device (computer, smartphone or tablet) to access and view the video (3-6 mins) over the course of 4 hospice telehealth visits, twice per week.

    Behavioral: NOVELA

  • No intervention
    Usual hospice care

    HFCGs will receive usual hospice care.

Interventions

  • BehavioralNOVELA

    The family caregivers that consent to participate will work with the interventionist to use a web-enabled device (computer, smartphone or tablet) to access and view the telenovela video (one of four episodes, each 3-6 mins) twice per week over the course of 4 hospice telehealth visits (one episode per visit). All four visits will use telehealth via video-conferencing. The number of visits is based on the number of videos which content is prioritized based on previous work. The interventionist will introduce the purpose and topic of the video, facilitate video viewing and then elicit clarifying questions and reinforce main message.

06

What researchers measure

Primary outcomes

  1. HFCG Anxiety Before and After NOVELA as Assessed by the Generalized Anxiety Disorder 7-item Scale

    Generalized Anxiety Disorder 7-item (GAD-7) scale. Family caregiver indicate the frequency participants have been bothered by generalized anxiety. Score range 0-21; higher scores reflect higher anxiety.

    Time frame: Baseline and 2 weeks

  2. HFCG Self-efficacy Before and After NOVELA as Assessed by the Caregiver Self-Efficacy Scale

    Caregiver Self-Efficacy Scale (CaSES) - 21-items, scale range 1-4,; higher scores reflect higher self-efficacy. Mean participant's scale choice is reported.

    Time frame: Baseline and 2 weeks

  3. HFCG Depression Before and After NOVELA as Assessed by the Patient Health Questionnaire 8-item Scale (PHQ-8)

    Patient Health Questionnaire (PHQ-8) - Score ranges from 0-24, higher scores reflect higher depressive symptoms.

    Time frame: Baseline and 2 weeks

07

Results

Posted Jun 30, 2026

Participant flow

Participant flow — Overall Study
MilestoneNOVELAUsual Hospice Care
Started3428
Completed1616
Not completed1812

Outcome measures

PrimaryHFCG Anxiety Before and After NOVELA as Assessed by the Generalized Anxiety Disorder 7-item Scale

Generalized Anxiety Disorder 7-item (GAD-7) scale. Family caregiver indicate the frequency participants have been bothered by generalized anxiety. Score range 0-21; higher scores reflect higher anxiety.

Time frame:
Baseline and 2 weeks
Reported as:
Mean · units on a scale
HFCG Anxiety Before and After NOVELA as Assessed by the Generalized Anxiety Disorder 7-item Scale
units on a scaleNOVELAUsual Hospice Care
Baseline5.39 ± 4.727.58 ± 5.72
2 weeks5.25 ± 4.148.20 ± 4.71
PrimaryHFCG Self-efficacy Before and After NOVELA as Assessed by the Caregiver Self-Efficacy Scale

Caregiver Self-Efficacy Scale (CaSES) - 21-items, scale range 1-4,; higher scores reflect higher self-efficacy. Mean participant's scale choice is reported.

Time frame:
Baseline and 2 weeks
Reported as:
Mean · units on a scale
HFCG Self-efficacy Before and After NOVELA as Assessed by the Caregiver Self-Efficacy Scale
units on a scaleNOVELAUsual Hospice Care
Baseline3.13 ± 0.423.12 ± 0.38
2 weeks3.17 ± 0.472.95 ± 0.40
PrimaryHFCG Depression Before and After NOVELA as Assessed by the Patient Health Questionnaire 8-item Scale (PHQ-8)

Patient Health Questionnaire (PHQ-8) - Score ranges from 0-24, higher scores reflect higher depressive symptoms.

Time frame:
Baseline and 2 weeks
Reported as:
Mean · units on a scale
HFCG Depression Before and After NOVELA as Assessed by the Patient Health Questionnaire 8-item Scale (PHQ-8)
units on a scaleNOVELAUsual Hospice Care
Baseline4.39 ± 4.565.96 ± 5.13
2 weeks4.31 ± 3.557.40 ± 3.50

Adverse events

Collected over From baseline up to 4 weeks.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
NOVELA0/34 (0%)0/34 (0%)0/34 (0%)
Usual Hospice Care0/28 (0%)0/28 (0%)0/28 (0%)

Baseline characteristics

Participants with data collected.

Age, Continuous
Age, Continuous(years)NOVELAUsual Hospice CareTotal
Mean59.1 ± 16.259.6 ± 13.859.3 ± 15.1
Sex: Female, Male
Sex: Female, Male(Participants)NOVELAUsual Hospice CareTotal
Female272653
Male729
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)NOVELAUsual Hospice CareTotal
Hispanic or Latino241943
Not Hispanic or Latino10919
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)NOVELAUsual Hospice CareTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American10919
White000
More than one race241943
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(Participants)NOVELAUsual Hospice CareTotal
United States342862
08

Study locations

1 site
  • Johns Hopkins Univeristy
    Baltimore, Maryland 21287, United States
09

References and documents

Publications

  • Crist JD, Pasvogel A, Hepworth JT, Koerner KM. The impact of a telenovela intervention on use of home health care services and Mexican American older adult and caregiver outcomes. Res Gerontol Nurs. 2015 Mar-Apr;8(2):62-76. doi: 10.3928/19404921-20150105-02. Epub 2015 Jan 16. PubMed 25594360 ↗
  • Cruz-Oliver DM, Malmstrom TK, Fernandez N, Parikh M, Garcia J, Sanchez-Reilly S. Education Intervention "Caregivers Like Me" for Latino Family Caregivers Improved Attitudes Toward Professional Assistance at End-of-life Care. Am J Hosp Palliat Care. 2016 Jul;33(6):527-36. doi: 10.1177/1049909115584315. Epub 2015 May 27. PubMed 26019262 ↗
  • Washington KT, Oliver DP, Benson JJ, Rolbiecki AJ, Jorgensen LA, Cruz-Oliver DM, Demiris G. Factors influencing engagement in an online support group for family caregivers of individuals with advanced cancer. J Psychosoc Oncol. 2020 May-Jun;38(3):235-250. doi: 10.1080/07347332.2019.1680592. Epub 2019 Nov 6. PubMed 31690247 ↗
  • Cruz-Oliver DM, Abshire M, Budhathoki C, Oliver DP, Volandes A, Smith TJ. Reflections of Hospice Staff Members About Educating Hospice Family Caregivers Through Telenovela. Am J Hosp Palliat Care. 2021 Feb;38(2):161-168. doi: 10.1177/1049909120936169. Epub 2020 Jul 8. PubMed 32638608 ↗

Study documents

  • Protocol and statistical analysis plan · Mar 4, 2025

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06835764
Lead sponsor
Johns Hopkins University
Collaborators
Maryland Cigarette Restitution Fund
Responsible party
Sponsor
First posted
Feb 19, 2025
Start date
Dec 1, 2024
Primary completion
Jan 30, 2026
Completion
Jan 30, 2026
Results posted
Jun 30, 2026
Last update
Jun 30, 2026

Study contacts

DULCE CRUZ-OLIVER, MD
principal investigator · Johns Hopkins University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion